IDORSIA LTD (IDRSF:OTCMKTS)

$4.95 -0.43 (-7.9926%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed IDORSIA LTD (IDRSF:OTCMKTS) News Sources

Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension

05-10-2026

yahoo.com

New results across pediatric, adult and real-world insomnia settings highlight the expanding clinical evidence for daridorexant at Sleep Europe 2026

08-10-2026

yahoo.com

Aprocitentan efficacy data reinforce endothelin pathway blockade as a distinct therapeutic approach across the cardiometabolic disease spectrum including obesity

12-10-2026

yahoo.com

Idorsia presents outstanding results with daridorexant in children and adolescents with insomnia and an expanding body of evidence in adults at Sleep Europe 2026

23-10-2026

yahoo.com

A new scientific avenue for daridorexant: Idorsia to advance development in autism spectrum disorder

26-10-2026

yahoo.com

Idorsia seeks US label update for QUVIVIQ daytime functioning benefits – first patients enrolled in Dari-Dream

27-10-2026

yahoo.com

Idorsia initiates pivotal Phase 3 study for lucerastat in Fabry disease and enters co-development and commercialization agreement with Nxera

28-10-2026

yahoo.com

Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets

28-10-2026

yahoo.com

Idorsia and SPV investors partner to unlock the blockbuster potential of TRYVIO/JERAYGO with a targeted launch in specialists

29-10-2026

yahoo.com

Idorsia reports accelerating QUVIVIQ growth, advances key value drivers, and reaffirms full-year financial guidance

29-10-2026

yahoo.com

IDORSIA LTD (IDRSF:OTCMKTS) Sentiment Trend

0 25 50 75 100 56 75 49 71 83 63 78 85 80 88 05-10-2026 08-10-2026 12-10-2026 23-10-2026 26-10-2026 27-10-2026 28-10-2026 29-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

IDORSIA LTD (IDRSF:OTCMKTS) FAQs

toggle

What is the current price of IDORSIA LTD (IDRSF:OTCMKTS)?

The current price of IDORSIA LTD (IDRSF:OTCMKTS) is $4.95.


toggle

IDORSIA LTD (IDRSF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of IDORSIA LTD (IDRSF:OTCMKTS) since the previous trading day is $-0.43.


toggle

IDORSIA LTD (IDRSF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of IDORSIA LTD (IDRSF:OTCMKTS) since the previous trading day is -7.9926%.


toggle

What is the most recent average sentiment score for IDORSIA LTD (IDRSF:OTCMKTS)?

The most recent average sentiment score for IDORSIA LTD (IDRSF:OTCMKTS) is 73 out of 100.


toggle

What is the most recent average sentiment for IDORSIA LTD (IDRSF:OTCMKTS)?

The most recent sentiment for IDORSIA LTD (IDRSF:OTCMKTS) is .


SEC-8K** Filing Available For IDORSIA LTD (IDRSF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.